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Abstract Exposure to altitude results in multiple physio-
logical consequences. These include, but are not limited to,
a reduced maximal oxygen consumption, drop in arterial
oxygen saturation, and increase in muscle metabolic per-
turbations at a fixed sub-maximal work rate. Exercise
capacity during fixed work rate or incremental exercise and
time-trial performance are also impaired at altitude relative
to sea level. Recently, dietary nitrate (NO3
-) supplemen-
tation has attracted considerable interest as a nutritional aid
during altitude exposure. In this review, we summarise and
critically evaluate the physiological and performance
effects of dietary NO3
- supplementation during exposure
to simulated and terrestrial altitude. Previous investigations
at simulated altitude indicate that NO3
- supplementation
may reduce the oxygen cost of exercise, elevate arterial and
tissue oxygen saturation, improve muscle metabolic func-
tion, and enhance exercise capacity/performance. Con-
versely, current evidence suggests that NO3
-
supplementation does not augment the training response at
simulated altitude. Few studies have evaluated the effects
of NO3
- at terrestrial altitude. Current evidence indicates
potential improvements in endothelial function at terrestrial
altitude following NO3
- supplementation. No effects of
NO3
- supplementation have been observed on oxygen
consumption or arterial oxygen saturation at terrestrial
altitude, although further research is warranted. Limitations
of the present body of literature are discussed, and direc-
tions for future research are provided.
Key Points
The findings of this review demonstrate that dietary
nitrate (NO3
-) supplementation may reduce the
oxygen cost of exercise, elevate arterial and tissue
oxygenation, improve muscle metabolic function,
and enhance exercise capacity/performance at
simulated altitude.
Current preliminary evidence from training studies
conducted at simulated altitude suggests that NO3
-
supplementation has no effect on performance-
related adaptations, although further investigations
are warranted.
Additional studies are required to confirm whether
the beneficial effects of NO3
- supplementation that
have been demonstrated at simulated altitude also
manifest at terrestrial altitude.
1 Introduction
Every year, millions of individuals ascend to altitude for
recreational, occupational, and sporting purposes [1].
Reasons for ascending to altitude include, amongst others,
tourism, hiking and mountaineering, skiing, military
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deployment, sports training camps, and athletic competi-
tion. With increasing altitude, there is a decrease in baro-
metric pressure and a concomitant decline in the partial
pressure of oxygen (PO2), such that the high-altitude
environment is hypoxic relative to sea level (normoxia).
Exposure to this hypoxic environment decreases the
amount of oxygen (O2) reaching the lungs, blood, and
ultimately tissue [2, 3]. Consequently, maximal O2 con-
sumption ( _VO2max) decreases [4, 5]. The absolute _VO2
necessary to maintain a given sub-maximal work rate is
typically the same at sea level and altitude up to*4300 m,
although it may be slightly reduced at higher altitudes (e.g.,
5260 m) consequent to alterations in substrate oxidation
[6]. Nevertheless, the relative percentage of _VO2max uti-
lized is higher at altitude relative to sea level [7]. As such,
muscle metabolic perturbations are increased [8–11]. Fur-
thermore, exercise time to exhaustion (TTE) and time-trial
(TT) performance are impaired at altitude compared with
sea level [7]. Prolonged altitude exposure results in
acclimatization, comprising multiple renal, cardio-pul-
monary, and hematological adaptations that act to increase
the delivery of O2 to the tissue [12]. However, these
adaptive changes can take days or weeks to fully manifest,
and sea-level exercise performance/capacity is never fully
attained, even with prolonged acclimatization [7].
Nitric oxide (NO) is a pleiotropic signaling molecule
and a regulator of multiple physiological processes, many
of which are altered by hypoxia, including mitochondrial
function [13, 14], cerebral and muscle tissue blood flow
[15–17], muscle metabolism [10, 11], and endothelial
function [18, 19]. NO plays a fundamental role in the
response to hypoxia and has been implicated in hypoxia-
induced vasodilation, a mechanism designed to ensure
appropriate matching between O2 delivery and the meta-
bolic demands of muscle and cerebral tissue when O2
availability is low [15, 20]. Elevated levels of NO [21],
alongside hematological (e.g., erythropoiesis and increased
hemoglobin mass) and ventilatory (e.g., increased hypoxic
ventilatory response) changes [22], have been associated
with successful adaptation and acclimatization to altitude
in lowlanders and altitude residents. In particular, Tibetan
highlanders who have adapted to the genetic selection
pressures of living at high altitude, manifest greatly
increased plasma and pulmonary NO bioavailability
[18, 23, 24]. Such adaptations afford distinctive metabolic
[25] and microcirculatory [18] benefits that translate into
an extraordinary capacity to cope with the challenges of
hypoxia relative to unacclimatized lowlanders. Conversely,
prior to acclimatization, lowlanders exhibit suppressed NO
bioavailability with altitude exposure, and both failure to
acclimatize and high-altitude illness have been associated
with insufficient NO generation in hypoxia [26–28].
Given the importance of NO during hypoxic exposure, it
has been widely speculated that increasing NO bioavail-
ability via dietary supplementation might confer beneficial
effects in individuals ascending to altitude [29–32].
Endogenous NO production occurs via two distinct and
uniquely different pathways that may be targeted to
increase NO generation. First, NO can be produced via
oxidation of the semi-essential amino acid L-arginine. This
reaction is catalyzed by the NO synthase (NOS) enzymes
and requires O2 as a co-substrate. In vitro evidence sug-
gests that NO generated via the L-arginine NOS pathway is
suppressed in hypoxia [33], although in vivo evidence is
less clear [34–36]. Alternatively, NO can be generated via
the reduction of nitrate (NO3
-) and nitrite (NO2
-) through
the recently elucidated NO3
-–NO2
-–NO pathway [37].
Consumption of NO3
--rich foods such as leafy green
vegetables and beetroot or NO3
--salts (e.g., sodium [Na]-
or potassium [K?]-NO3
-) rapidly and substantially ele-
vates plasma [NO3
-] (square brackets denote concentra-
tion) [38]. Exogenous NO3
- mixes with endogenously
derived NO3
-, which is an oxidation product of the L-
arginine NOS pathway, in the blood and can be slowly
reduced to NO2
- by the enzyme xanthine oxidoreductase
[39]. A more rapid pathway for NO3
- reduction also exists,
which is facilitated through recirculation of NO3
- into the
mouth via the salivary glands [40]. Here, oral bacteria
reduce NO3
- to NO2
- via reductase enzymes [41]. A
portion of the bacterially generated NO2
- is transformed
into NO in the stomach [42, 43]. However, the majority
enters systemic circulation and may be further reduced to
NO via enzymatic and non-enzymatic catalysts [37, 44]
including, amongst others, xanthine oxidoreductase
[45, 46], deoxygenated hemoglobin [47] and myoglobin
[48], and cytochrome c oxidase (COX) [49]. Importantly,
these pathways for NO generation via NO2
- reduction are
all considerably enhanced in hypoxic conditions [37]. The
NO3
-–NO2
-–NO pathway is therefore of particular
importance in hypoxia and is viewed as an important
‘‘back-up’’ system for maintaining and/or enhancing NO
bioavailability and signaling in this environment (Fig. 1). It
should be noted that recent evidence suggests a possible
direct role of NO2
- on skeletal muscle and mitochondrial
function and in hypoxia-induced vasodilation [50]. Thus,
any effects of NO3
- consumption might, at least in part, be
related to NO2
--dependent signaling, rather than being
solely attributable to NO [50].
Interestingly, recent evidence from studies conducted at
sea level suggests that NO3
- supplementation can reduce
resting blood pressure (BP) [51–53], lower the O2 cost of
exercise [54–56], and augment both exercise capacity and
performance [55, 57–59]. Logically, greater effects of
NO3
- supplementation might be expected in hypoxia,
given the particularly important role that NO plays in this
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environment and that NO production via the L-arginine
NOS pathway is suppressed yet NO2
- reduction is
enhanced in hypoxia. Furthermore, a reduced O2 cost of
exercise is likely to be especially meaningful for individ-
uals exercising in a low-O2 environment.
Although several recent articles have been published
reviewing the potential benefits of dietary NO3
- supple-
mentation at sea level [31, 32, 59–61], there is presently no
review of the literature focusing on its specific applications
for individuals exercising at altitude, despite a considerable
and broad body of evidence emerging in the area. The
purpose of the present review is to address this need by
summarizing and critically evaluating the findings of recent
research exploring the effects of NO3
- supplementation on
cardiopulmonary and metabolic responses to exercise and
exercise performance at altitude. The potential effects of
NO3
- supplementation on adaptations to altitude training
are also explored. Throughout the review, key limitations
of the present body of evidence will be discussed and
directions for future research suggested.
2 Study Selection and Characteristics
Studies were identified for this review by searching online
journals and the databases PubMed and SPORTDiscus.
This review includes studies that assessed the effects of
NO3
- supplementation during both acute (*1–5 h) and
chronic (1–28 days) altitude exposure. We included studies
conducted at terrestrial altitude, simulated altitude via
normobaric hypoxia (i.e., the altitude PO2 is replicated by
lowering the fraction of inspired O2 [FIO2] whilst main-
taining sea-level barometric pressure), and hypobaric
hypoxia (i.e., the altitude PO2 is replicated by lowering the
barometric pressure whilst the FIO2 is unchanged from sea-
level values). Terrestrial altitudes ranged from 1300 to
5300 m. Reported simulated altitudes were
*2500–5000 m (FIO2 11–15.4%) in normobaric hypoxia
and 3500 m in a hypobaric chamber. The dose of NO3
-
ranged from *5 to 15.2 mmolday-1. Supplementation
duration ranged from an acute dose 1.5–3 h pre-trial, to
chronic loading for up to 11 days.
Fig. 1 A schematic representation of the metabolic pathways for
nitric oxide (NO) generation in the human body (adapted from Jones
[32], with permission). The ‘traditional’ pathway for NO generation
involves oxidation of the semi-essential amino acid L-arginine, in a
reaction which requires the availability of O2 and is catalysed via the
NO synthase (NOS) enzymes. This O2-dependent reaction is
suppressed in hypoxia. Alternatively, NO can be generated via the
nitrate (NO3
-)–nitrite (NO2
-)–NO pathway. Here, NO3
- from
dietary sources or produced as an oxidation product of the L-arginine
pathway is reduced into NO2
- via oral bacteria (a rapid pathway) or
via the enzyme xanthine oxidoreductase (XOR) (a slower pathway).
NO2
- can subsequently be reduced into NO via multiple catalysts,
particularly under conditions of low O2 availability. This second
pathway may serve to maintain or enhance NO signalling under
conditions of hypoxia, such as that experienced at an altitude
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3 Physiological Effects of Nitrate (NO3
2)
Supplementation in Hypoxia
3.1 Oxygen (O2) Consumption During Steady-State
Constant Work-Rate Exercise
Larsen et al. [54] first reported a reduction in steady-state
_VO2 consequent to NO3
- supplementation with _VO2 *5%
lower during cycle ergometry exercise in normoxia. This
effect was unexpected, as the _VO2 requirement of a given
workload is typically regarded as unchangeable, but has
since been confirmed in multiple subsequent investigations
in normoxia [38, 55–57, 62, 63].
Masschelein et al. [29] confirmed the O2-sparing effect
of NO3
- supplementation during exercise in normobaric
hypoxia. _VO2 was *4% lower during cycle ergometry
exercise at 45% peak O2 uptake ( _VO2peak) in extreme
normobaric hypoxia (FIO2 11%, *5000 m). Subsequent
studies have reported _VO2 reductions of 4–10% (similar
magnitudes to those reported in normoxia) during cycle
ergometry [29, 30, 36] and treadmill running exercise [64]
across a range of simulated altitudes (FIO2 11–15.4%,
*2500–5000 m). Interestingly, one study reported lower
steady-state _VO2 in normobaric hypoxia (FIO2 13.1%,
*3500 m) but not normoxia [36] following NO3
- sup-
plementation. This suggests that NO3
- supplementation
might be especially effective at reducing the O2 cost of
exercise in hypoxia, possibly due to greater conversion of
NO2
- into NO and/or more effective modulation of O2-
consuming cellular processes.
To the authors’ knowledge, only one study has reported
the effects of NO3
- supplementation on _VO2 during acute
exercise in hypobaric hypoxia [65]. In contrast to some
evidence obtained in normobaric hypoxia, NO3
- supple-
mentation did not influence _VO2 during cycle ergometry
exercise in a hypobaric hypoxic chamber simulating
3500 m altitude. These inconsistent findings are puzzling
but might be related to the high training status of the par-
ticipants ( _VO2max at 1600 m altitude:*61 mlkg-1min-1;
see Sect. 4 for details of how training status may modulate
the effects of NO3
- supplementation) rather than the
exercise environment. Supporting this notion, three recent
studies have reported no effect of NO3
- supplementation
on _VO2 during sub-maximal exercise in normobaric
hypoxia (FIO2 11–15.4%, *2500–5000 m) in highly-
trained individuals ( _VO2max:[60 mlkg-1min-1) [66–68].
Moreover, a recent investigation at sea level reported a
significant inverse relationship between _VO2peak and the
reduction in _VO2 consequent to NO3
- supplementation
[58]. However, direct comparison of the effects of NO3
-
ingestion on _VO2 in normobaric and hypobaric hypoxia is
warranted to exclude the influence of other potentially
confounding methodological variables.
The reduction in _VO2 subsequent to NO3
- supplemen-
tation is unlikely to be related to a shift towards anaerobic
adenosine triphosphate (ATP) generation, as blood [lactate]
[54], muscle pH [69], and glycolytic ATP turnover [62] are
typically unchanged following NO3
- ingestion. Instead, it
has been suggested that the lower _VO2 reported after NO3
-
supplementation might be related to improvements in the
efficiency of muscle force generation [62] and/or mito-
chondrial respiration [70].
In the study by Bailey et al. [62], NO3
- supplementation
attenuated intramuscular phosphocreatine (PCr), adenosine
diphosphate (ADP), and inorganic phosphate (Pi) pertur-
bations and lowered _VO2 during leg-extension exercise in
normoxia, suggesting a lower ATP cost of muscle force
generation [62]. The ATP cost of muscle force production
is primarily accounted for by cross-bridge cycling and
calcium (Ca2?) handling [71, 72]. Given NO has been
demonstrated to slow cross-bridge cycling kinetics [73, 74]
and inhibit Ca2?-ATPase activity [75, 76], the lower ATP
requirement of muscle force generation following NO3
-
supplementation may be related to a NO-mediated reduc-
tion in the ATP cost of one or both of these processes [62].
Recently, Hernandez et al. [77] reported increased muscle
force generation and elevated expression of the Ca2?
handling protein calsequestrin 1 and the dihydropyridine
receptor in murine type II muscle fibers following NO3
-
supplementation. It was proposed that similar effects in
humans might allow muscle activation at a lower frequency
for an equivalent force production, thus decreasing motor
unit recruitment and lowering the ATP cost (and therefore
improving the efficiency) of force production.
Larsen et al. [70] reported improvements in mitochon-
drial efficiency following NO3
- supplementation. Supple-
mentation with NaNO3
- for 3 days increased the
phosphate/O2 (P/O) ratio of mitochondria harvested from
the vastus lateralis of healthy men, an effect that was sig-
nificantly correlated with the reduced in vivo _VO2. The
authors reported reduced expression of the ATP/ADP
translocase protein (ANT) and a tendency towards reduced
expression of uncoupling protein 3 (UCP3). Such effects
may have reduced proton leak during oxidative phospho-
rylation and could account for the improved P/O ratio and
lower pulmonary _VO2 [70]. It was proposed that these
changes to protein expression may manifest as a conse-
quence of NO competitively inhibiting O2 binding to COX
[78], which may be detected by the mitochondria as
hypoxia, activating signaling pathways that downregulate
ANT [70]. Given greater inhibition of COX would be
expected when PO2 is low, it is possible that this mecha-
nism may be more active in hypoxia than in normoxia [61].
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In contrast to the findings of Larsen et al. [70], Whitfield
et al. [79] reported no effect of NO3
--rich beetroot juice on
mitochondrial efficiency despite a reduced _VO2. These
disparate results may be related to the form of NO3
-
administered (i.e., NaNO3
- vs. beetroot juice), although
direct comparison is required to eliminate other method-
ological discrepancies [80]. Interestingly, one recent study
[81] reported greater reductions in _VO2 following beetroot
juice versus NaNO3
- supplementation in normoxia, pos-
sibly as a consequence of the beetroot juice polyphenols
and antioxidants enhancing NO generation, further sug-
gesting different effects of these two NO3
--containing
supplements.
3.2 O2 Uptake Kinetics
Normoxic studies have reported faster phase II _VO2
kinetics during the transition from moderate to severe [82],
but not unloaded to moderate [55, 82, 83], intensity exer-
cise following NO3
- supplementation. The apparently
greater effects of NO3
- during the moderate to severe
intensity transition might be related to type II muscle fiber-
specific effects of NO3
- [61, 77, 84], given greater relative
activation of these fibers during this transition [82]. In
hypoxia, _VO2 kinetics are typically slowed compared with
normoxia [36, 85]. Interestingly, Kelly et al. [36] observed
faster phase II _VO2 kinetics during the step transition from
unloaded to moderate-intensity but not moderate- to sev-
ere-intensity exercise in normobaric hypoxia [36]. Con-
versely, NO3
- supplementation did not influence _VO2
kinetics in normoxia in this study [36]. The precise reasons
why NO3
- had no effect on _VO2 kinetics during the
moderate to severe transition in hypoxia, or either transi-
tion in normoxia, are unclear. Nevertheless, the speeding of
_VO2 kinetics during the unloaded to moderate-intensity
exercise transition might be beneficial by reducing the time
required to reach a steady state and thus minimizing the
incurred O2 deficit [86].
3.3 Arterial O2 Saturation
NO3
- supplementation has been reported to result in a
small (1–4%) increase in arterial O2 saturation (SaO2), as
assessed via pulse oximetry, in some [29, 30, 64, 68] but
not all [36] studies during acute exposure to normobaric
hypoxia. Carriker et al. [65] observed no effects of NO3
-
on SaO2 during acute exercise in a hypobaric hypoxic
chamber (*3500 m).
Only one study has examined the effects of NO3
- sup-
plementation on SaO2 at terrestrial altitude [87]. Hennis
et al. [87] observed no effect of NO3
- on SaO2 during an
11-day trek to Mount Everest Base Camp (*5300 m). The
lack of effect in this study may be related to the chronic
hypoxic exposure and gradual altitude ascent. Here,
endogenous NO generation may be elevated with
acclimatization [21], thus potentially diminishing the reli-
ance on exogenous NO3
- as a substrate for NO generation.
NO3
- might therefore be more effective during acute
altitude exposure prior to acclimatization, where NO
bioavailability is reduced. However, this awaits direct
investigation.
Apnea (i.e., breath holding) investigations provide fur-
ther insight into the effects of NO3
- supplementation on
SaO2 when O2 availability is restricted. NO3
- supplemen-
tation has been reported to elevate SaO2 during static [88]
and dynamic [89] apneas. Conversely, Schiffer et al. [90]
observed lower SaO2 values and decreased static apnea
duration following NO3
- supplementation. However,
NO3
- supplementation tended to elevate SaO2 during a
maximal dynamic apnea. These conflicting results might be
related to methodological differences between studies,
including the type of apnea (e.g., static vs. dynamic,
underwater vs. ‘dry’), NO3
- supplementation strategy, and
pre-apnea hyperventilation procedures. Nevertheless, the
evidence that NO3
- supplementation can elevate SaO2 in
certain apnea situations, particularly during dynamic
apnea, provides support for the increase in SaO2 observed
during exercise in hypoxia [29, 30, 64, 68].
Mechanistically, the elevated SaO2 reported during
exercise in hypoxia following NO3
- supplementation may
be due to reduced muscle O2 extraction consequent to
improvements in the efficiency of muscle contraction [62]
and/or mitochondrial respiration [70]. Additionally, in one
study, NO3
- supplementation increased pulmonary venti-
lation ( _VE) in conjunction with an elevated SaO2 during
exercise in hypoxia [68]. Given a higher _VE has previously
been associated with reduced arterial desaturation [91], it is
possible that an increased _VE following NO3
- supple-
mentation might also play a role in elevating SaO2. An
elevated SaO2 could have important implications for
hypoxic exercise performance, as discussed in Sect. 4.
Theoretically, an elevated SaO2 could also help attenuate
acute mountain sickness [92], although current studies have
reported no significant effect of NO3
- on acute mountain
sickness [29, 87].
3.4 Tissue Oxygenation
Masschelein et al. [29] reported an increase in the near-
infrared spectroscopy (NIRS)-derived tissue oxygenation
index (TOI) of the vastus lateralis during cycle ergometry
exercise in normobaric hypoxia (FIO2 11%, *5000 m)
following NO3
- supplementation. Kelly et al. [36] also
reported a tendency towards elevated TOI during
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moderate-intensity exercise in normobaric hypoxia (FIO2
13.1%, *3500 m). The TOI reflects the ratio between
absolute values of oxygenated and total haemoglobin plus
myoglobin, and therefore provides a measure of local
oxygenation status. Masschelein et al. [29] interpreted the
increased TOI as reflecting a greater O2 efficiency conse-
quent to NO3
-. Alternatively, the increased TOI could
reflect a greater O2 delivery to the muscle due to elevated
tissue blood flow [93]. As both hypoxia [94] and NO3
-
[95] have been reported to increase tissue blood flow, this
second explanation cannot be excluded. Given the possible
influence of skin blood flow (which increases for ther-
moregulatory purposes during exercise) on the NIRS signal
[96], caution is also advised when interpreting these data.
Additional information on the strengths and limitations of
NIRS is presented elsewhere [93, 97].
3.5 Muscle Metabolism
Exposure to hypoxia reduces both arterial and intracellular
PO2 [3]. This has a deleterious effect on muscle metabolic
function, reducing the capacity for oxidative ATP resyn-
thesis [8, 14], increasing the degradation of limited meta-
bolic substrates including muscle glycogen and PCr and
elevating the accumulation of fatigue-associated metabo-
lites such as H?, Pi, and ADP [9–11]. These factors
potentially contribute towards the decreased exercise tol-
erance in hypoxia [98]. Intriguingly, Vanhatalo et al.
[11, 99] provide evidence to suggest that NO3
- supple-
mentation might ameliorate the undesirable effects of
hypoxia on muscle metabolic function.
NO3
- supplementation attenuated the rate of change in
muscle [PCr], [Pi], and pH as assessed via
31phosphorus-
magnetic resonance spectroscopy (31P-MRS) during leg
extension exercise in normobaric hypoxia (FIO2 14.5%,
*2800 m) [11]. Muscle PCr recovery, reflective of muscle
oxidative capacity, was restored to normoxic values. In a
follow-up study in more severe hypoxia (FIO2 13%,
*3500 m), the faster PCr recovery kinetics with NO3
-
supplementation were associated with an accelerated
effective transverse relaxation time (T2*), as obtained via
magnetic resonance imaging (MRI) [99]. The T2* signal is
a result of both blood flow to the area under investigation
and the oxygenation status of the blood and tissue. Con-
sequently, an increase in blood volume and/or the pro-
portion of oxygenated blood increases the T2* signal [100].
The authors speculated that the accelerated T2* recovery
following NO3
- supplementation may indicate a greater
delivery of freshly oxygenated blood to the muscle,
increasing the O2 driving pressure into the muscle cells,
and resulting in faster oxidative ATP resynthesis and PCr
regeneration [99]. NO3
- supplementation also improved
mitochondrial efficiency, as indicated by an increased
muscle phosphorylation potential (indicative of the proton
motive force) and lower Gibb’s free energy (DG) [99].
Interestingly, resting [PCr] was reduced consequent to
NO3
- supplementation, with the magnitude of the decline
inversely correlated with plasma [NO2
-]. It was speculated
that this might be related to reversible S-nitrosation of
creatine kinase (CK), and could serve to enhance mito-
chondrial sensitivity to ADP stimulation. Thus, NO3
-
supplementation may enhance both muscle energetics and
O2 delivery during hypoxic exercise, which might partly
underpin the improvements in exercise performance dis-
cussed in Sect. 4.
3.6 Cardiovascular Response
In normoxia, NO3
- supplementation has been reported to
reduce BP [51–53] and enhance vascular compliance [101]
in humans and improve cardiac contractility in rodents
[102]. Dietary NO3
- might also provide a means of alter-
ing the complex and multifaceted cardiovascular response
to hypoxia.
Some [11, 64], but not all [68, 103], previous studies
have reported BP reductions during acute normobaric
hypoxic exposure following NO3
- supplementation. The
reduced BP following NO3
- supplementation has been
attributed to increased NO2
- and NO generation and sub-
sequent vasodilation [52, 53]. Recently, Ingram et al. [104]
reported pulmonary and arterial vasodilation after NO2
-
infusion in normobaric hypoxia (FIO2 12%,*4100 m) but
not normoxia. The greater activity of NO2
- reductases,
including xanthine oxidoreductase, deoxygenated hemo-
globin, and myoglobin, and COX in hypoxia [37] may
partly explain this effect. Interestingly, Ingram et al. [104]
observed pulmonary vasodilation in hypoxia after plasma
[NO2
-] had returned to baseline values. This suggests
possible storage and metabolism of NO2
-, and NO in the
extravascular tissue could contribute to hypoxia-induced
vasodilation [104]. It is possible, based on the findings of
Ingram et al. [104], that the capacity to elicit vasodilation
and BP effects with NO3
- supplementation might also be
more likely in hypoxia than in normoxia, although direct
comparison is required.
In acute normobaric hypoxia (FIO2*11.6%,*4600 m),
NO3
- supplementation neither influenced the hemodynamic
response nor augmented cardiac unloading in healthy men
[103]. Similarly, NO3
- had no effect on the hypoxia-induced
hyperemic response to handgrip exercise in young adults
(mean ± standard deviation [SD] age 25 ± 1 years) exer-
cising in normoxia and acute normobaric hypoxia (FIO2
titrated to achieve*80% SaO2) [105]. Interestingly, despite
similar increases in plasma [NO2
-], NO3
- supplementation
significantly increased the vasodilation and blood flow
response to hypoxic exercise in older participants
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(mean ± SDage 64 ± 2 years). Themagnitude of the effect
was such that age-related differences in compensatory
vasodilation were abolished with NO3
- supplementation,
suggesting therapeutic utility of NO3
- in older populations
exercising in hypoxia [105] or potentially those afflictedwith
clinical conditions involving tissue hypoxia [106].
Limited evidence is available regarding the effects of
NO3
- on cardiovascular parameters at terrestrial altitude.
Bakker et al. [19] andHennis et al. [87] reported no effects of
NO3
- supplementation on BP during prolonged treks at
terrestrial altitude. However, in the study by Bakker et al.
[19], acute NO3
- ingestion offset the decline in endothelial
function assessed via flow-mediated vasodilation (FMD) in
healthy young participants (mean ± SD age 25 ± 5 years)
during an expedition in Nepal (28 days[2500 m, including
a peak of 3700 m). FMD has traditionally been viewed as
reflecting NO-dependent vasodilation of the smooth muscle
in response to acute hyperemia following circulatory
occlusion [107, 108]. The hyperemia that manifests fol-
lowing occlusion is believed to increase G-protein expres-
sion of phosphokinase A and subsequently increase activity
of endothelial NOS (eNOS) [108]. NO is then generated via
eNOS catabolism of L-arginine, which ultimately results in
smooth muscle relaxation and vasodilation [108]. Based on
this conventional view, Bakker et al. [19] primarily attrib-
uted the beneficial effects ofNO3
- supplementation on FMD
to elevated NO bioavailability via the NO3
-–NO2
-–NO
pathway and subsequent effects on smooth muscle. How-
ever, there exists considerable debate about the NO-depen-
dency of this technique, with some authors supporting
[109–111] and others questioning [112–115] the role of NO
in FMD assessment. Further exploration may therefore be
warranted to understand the precise mechanisms through
which NO3
- supplementation influences FMD.
4 Hypoxic Exercise Performance
Several studies have examined the effects of NO3
- inges-
tion on exercise capacity/performance in acute normobaric
hypoxia (Table 1). The effects of NO3
- supplementation
on exercise capacity/performance in simulated altitude via
hypobaric hypoxia and at terrestrial altitude have yet to be
investigated. Vanhatalo et al. [11] were the first to study the
effects of NO3
- supplementation during exercise in nor-
mobaric hypoxia (FIO2 14.5%, *2800 m) and observed a
21.4% increase in leg-extension TTE with NO3
- supple-
mentation. This improvement effectively restored exercise
duration to normoxia values. Whilst exhaustive leg-exten-
sion exercise is not directly representative of athletic per-
formance, these data suggest that NO3
- supplementation
might offer a means of ameliorating the ergolytic effects of
hypoxia on exercise performance.
Masschelein et al. [29] confirmed the beneficial effects
of NO3
- supplementation in extreme normobaric hypoxia
(FIO2 11%,*5000 m). Cycle ergometry TTE was reduced
by 36% in hypoxia versus normoxia. However, NO3
-
supplementation attenuated *5% of this ergolytic effect.
The magnitude of this effect is substantially lower than that
reported by Vanhatalo et al. [11], although it is likely of
practical relevance to an athlete and may be accounted for
by methodological differences. Notably, in the study by
Vanhatalo et al. [11], exercise was conducted in moderate
hypoxia involving a small muscle group, whereas Mass-
chelein et al. [29] had participants complete whole-body
exercise in severe hypoxia. In the former, a beneficial
effect of NO3
- on muscle O2 efficiency may result in a
direct and substantial improvement in performance, given
muscles are over perfused and muscle _VO2 is predomi-
nantly limited by mitochondrial O2 consumption rather
than delivery of O2 to the muscle [11]. In the latter, muscle
O2 consumption is limited primarily by impaired O2 dif-
fusion, consequent to the drop in arterial PO2, such that
greater O2 efficiency may result in smaller performance
improvements [29]. Additionally, constant-load TTE tests,
as employed by Vanhatalo et al. [11], are typically more
sensitive than incremental TTE tests for detecting
improvements in exercise capacity [29, 116].
Muggeridge et al. [30] first assessed the effects of NO3
-
supplementation on TT performance rather than TTE in
normobaric hypoxia (FIO2 15%, *2500 m). Performance
in a pre-loaded (i.e., preceded by a steady-state period)
16.1-km cycle ergometry TT was significantly faster
(2.2%) following NO3
- supplementation. Kelly et al. [36]
reported similar beneficial effects of NO3
- on severe-in-
tensity cycle ergometry TTE in physically active males
(mean ± SD _VO2peak: 58.3 ± 6.3 mlkg-1min-1) exer-
cising in normobaric hypoxia (FIO2 13.1%, *3500 m).
Interestingly, NO3
- supplementation did not influence
exercise tolerance in normoxia in this study [36], sup-
porting the notion that the ergogenic effects of NO3
- might
be particularly pronounced in conditions of low O2 avail-
ability. Most recently, Shannon et al. [64] reported a sig-
nificant improvement in pre-loaded 1500-m running TT
performance in normobaric hypoxia (FIO2 *15%,
*2500 m) following NO3
- supplementation in partici-
pants across a range of different fitness levels ( _VO2max
range: 47.1–76.8 mlkg-1min-1). All 12 participants in
that study were faster with NO3
- supplementation than
with placebo, with an average improvement in 1500 m TT
performance of 3.2%.
However, not all studies have observed a positive effect
of NO3
- supplementation on hypoxic exercise perfor-
mance. MacLeod et al. [66] reported no effects of NO3
-
supplementation on 10-km cycle ergometry TT
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performance in well-trained athletes (mean ± SD _VO2peak
67.5 ± 5.8 mlkg-1min-1) exercising in either normo-
baric hypoxia (FIO2 *15%, *2500 m) or normoxia.
Likewise, Bourdillon et al. [68] observed no significant
difference in 15-km cycle ergometry TT performance in
extreme normobaric hypoxia (FIO2 11%, *5000 m) or
normoxia following NO3
- supplementation. However,
there was a non-significant tendency towards improved
performance (*151 s faster) in hypoxia with NO3
-
ingestion. Similarly, Arnold et al. [67] reported no effect of
NO3
- ingestion on 10-km TT running performance in
moderate normobaric hypoxia (FIO2 15.4%, *2500 m) or
incremental running performance in extreme normobaric
hypoxia (FIO2 12.8%,*4000 m) in highly trained runners
(mean ± SD _VO2max 66 ± 7 mlkg-1min-1).
These conflicting results might be explained by
methodological differences between investigations. At
present, some evidence exists to suggest that the training
status of participants, exercise protocol, supplementation
protocol, and exercise environment (i.e., the degree and
duration of hypoxic exposure) can all moderate the effects
of NO3
- supplementation [31]. However, it should be
noted that none of these variables alone can entirely
explain the apparent ergogenic effect of NO3
- supple-
mentation (or lack thereof), and it is the interaction
between these and other factors that appears to be
important.
In several normoxic studies, high aerobic fitness has
been suggested as a possible reason for minimal effects of
NO3
- on exercise performance [117–122]. Notably, Por-
celli et al. [58] suggested that untrained and moderately
trained ( _VO2max\60 mlkg-1min-1) individuals are more
likely to benefit from NO3
- supplementation than endur-
ance-trained athletes ( _VO2max [60 mlkg-1min-1). How-
ever, given the cross-sectional nature of this study and
relatively modest sample size (fitness-stratified sub-groups
of six to eight participants), these data should be inter-
preted with caution. Moreover, a recent meta-analysis
found no influence of aerobic fitness on the response to
NO3
- supplementation [59], bringing into question this
relationship. Nevertheless, as evident in Shannon et al.
[64], who observed beneficial effects of NO3
- in partici-
pants across a spectrum of fitness levels during exercise in
moderate normobaric hypoxia, a high training status does
not entirely preclude an ergogenic effect of NO3
- supple-
mentation. Given that NO3
- supplementation appears to be
more effective in hypoxia than in normoxia [123], it is
possible that individuals who may not benefit from NO3
-
supplementation in normoxia (or at low/moderate altitudes)
might derive an ergogenic effect in extreme hypoxia where
the NO3
-–NO2
-–NO pathway is enhanced yet NOS
activity is suppressed.
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NO3
- supplementation appears to be most effective
during short-duration high-intensity exercise, although
data are presently limited regarding the effects of NO3
-
on this type of exercise at altitude. During short-duration
high-intensity activity, the cellular environment is likely
to be particularly hypoxic and acidic, potentiating NO2
-
reduction into NO [49, 124]. Moreover, type II muscle is
likely to be highly activated, and compelling evidence
from murine models suggests that NO3
- supplementation
might solely increase perfusion to [84, 95] and contractile
function/force generation of [77] type II muscle. Whilst a
precise ‘cut-off’ duration or exercise intensity for the
effects of NO3
- supplementation to be meaningful has yet
to be established and will likely differ depending on other
experimental factors, it appears that NO3
- supplementa-
tion is usually beneficial for exercise tests lasting
\30 min [55, 57, 58, 62, 63, 125, 126], but usually not
longer [117, 118, 120, 127], at least in normoxia. Exercise
at altitude, particularly mountaineering and hiking, can
include sustained periods of relatively low-intensity
activity. The effects of NO3
- supplementation on key
physiological and functional (e.g., walking distance in a
given time period) parameters during this type of exercise
warrant further study, especially as only a small propor-
tion of people ascending to altitude are highly trained
athletes conducting high-intensity exercise. Interestingly,
Kuennen et al. [128] reported a lower O2 cost of exercise
during a simulated desert march in the heat (41 C)
consequent to NO3
- supplementation. Given the similar-
ity of this exercise mode to altitude hiking (i.e., relatively
low-intensity walking whilst carrying a backpack), it is
possible that NO3
- supplementation might also reduce O2
consumption during altitude hiking, although this has yet
to be investigated. The effect of NO3
- supplementation at
lower altitudes (\2500 m [sea level) also remains
unexplored yet is of interest given physiological func-
tioning may be influenced by altitudes as low as
300–800 m [4].
Finally, normoxic studies suggest the supplementation
strategy might influence the ergogenic effects of NO3
-.
First, there is evidence to indicate a possible dose response
to NO3
- supplementation [38, 129, 130]. Likewise, some
effects of NO3
-, particularly those requiring changes in
protein expression [70, 77], may require several days to
occur, suggesting chronic loading may be more effective
than acute supplementation [59, 63]. Interestingly, Flueck
et al. [81] reported greater reductions in _VO2 with beetroot
juice than with NaNO3
- supplementation, which could be
related to greater NO2
- reduction into NO with beetroot
juice consequent to the polyphenols and/or antioxidants.
The potential influence of these moderators awaits inves-
tigation in hypoxia.
4.1 Simulated Versus Terrestrial Altitude
To date, few studies have explored the efficacy of NO3
-
supplementation during exposure to terrestrial altitude
[19, 87, 131], presumably because of the high financial
costs and logistical difficulties associated with such
investigations. Instead, researchers have typically admin-
istered inspired hypoxic gas during exercise or conducted
exercise in normobaric or (to a lesser degree) hypobaric
hypoxic chambers. There is ongoing debate about potential
differences in the physiological response to normobaric
hypoxia and terrestrial altitude [132], including potential
disparities in NO metabolism [133]. Further investigations
into the effects of NO3
- at terrestrial altitude and/or con-
trasting the effects of NO3
- supplementation between ter-
restrial and simulated altitude is warranted. It seems likely
that NO3
- supplementation could enhance exercise per-
formance at terrestrial altitude, given exercise performance
is predominantly limited by the low PO2 in both normo-
baric and hypobaric hypoxia [29]. Furthermore, NO3
-
supplementation has been reported to improve endothelial
function at terrestrial altitude, suggesting the potential to
alter peripheral vascular function in this environment [19].
Given the large degree of ‘‘noise’’ associated with field-
based testing, future studies may require large sample sizes
to ensure sufficient power to detect any meaningful phys-
iological changes with NO3
- supplementation.
5 Training in Hypoxia
There remains a degree of ambiguity over the performance
effects of NO3
- supplementation during exercise in
hypoxia, as discussed in Sect. 4. Nevertheless, it is possible
that NO3
- supplementation could help augment the phys-
iological and performance adaptations to training in
hypoxia, if the maintainable work rate during training
sessions was enhanced or prolonged. Moreover, NO has
been implicated in the adaptation to hypoxia [21] and
appears to play a role in skeletal muscle hypertrophy and
fiber-type transitions [134] and endothelial adaptations
[135], but not mitochondrial biogenesis [136, 137], fol-
lowing exercise training. Increasing NO bioavailability via
NO3
- supplementation might therefore enhance some of
the adaptations to hypoxic training. Conversely, it is also
possible that NO3
- might suppress hypoxic training
adaptations by limiting the drop in arterial and muscle O2
saturation, factors that could serve as ‘‘signals’’ for adap-
tation to hypoxic training [138].
Puype et al. [138] found no effect of NO3
- supple-
mentation on the physiological and performance adapta-
tions to 6 weeks of high-intensity endurance training
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(5 9 30 minweek-1 cycle ergometry at 4–6 mmoll-1
blood [lactate]) in normobaric hypoxia (FIO2 12.5%,
*4000 m). Improvements in _VO2max, power output at the
onset of blood lactate accumulation (OBLA; 4 mmoll-1
blood [lactate]) and average power output during a 30-min
TT in normoxia were similar in NO3
- and placebo con-
ditions. Likewise, the pre- to post-hypoxic training change
was similar between groups for muscle adenosine
monophosphate-activated kinase (AMPK) protein content
and phosphorylation, hypoxia-inducible factor (HIF)-1a
messenger RNA (mRNA) content, and glycogen break-
down during the TT. More recently, De Smet et al. [139]
explored the effects of NO3
- on adaptations to sprint
interval training (SIT) in normobaric hypoxia (FiO2 15%,
*2500 m) versus separate unsupplemented normoxic and
hypoxic training groups. Participants completed 3 9 4–6
maximal 30 s cycle ergometry sprints per week over a
5-week period. The proportion of type IIa fibers was sig-
nificantly increased in the hypoxic NO3
- group, whereas
the proportion of type IIx fibers was significantly
decreased. By contrast, a significant decrease in the pro-
portion of type IIx fibers in the unsupplemented groups did
not lead to significant increases in other fiber-type groups.
These findings were coupled with a tendency towards
greater improvements in normoxic 30-s sprint performance
in the hypoxic NO3
- training group relative to the hypoxic
unsupplemented training group. Conversely, performance
in a 30-min TT completed in normoxia increased by similar
amounts in all groups. Taken together, the results of Puype
et al. [138] and De Smet et al. [139] suggest that NO3
-
supplementation consumed during 5–6 weeks of endurance
or sprint training in hypoxia has minimal effects on phys-
iological adaptations or on exercise performance in
normoxia.
Two studies have also recently explored the effects of
NO3
- supplementation on the adaptations to SIT in nor-
moxia [140, 141]. Muggeridge et al. [140] reported greater
improvements in maximal work rate during incremental
exercise and indices of repeated high-intensity perfor-
mance in participants who ingested NO3
- versus placebo
prior to SIT sessions (3 9 4–6 maximal 15 s cycle
ergometry sprints per week, for 3 weeks). Thompson et al.
[141] also demonstrated greater improvements in peak
work rate during incremental exercise in individuals who
performed SIT (3–4 9 4–5 maximal 30 s cycle ergometry
sprints per week for 4 weeks) with NO3
- compared with
both training individuals given a placebo and NO3
--sup-
plemented individuals who did not train. Interestingly, and
supporting the findings of De Smet et al. [139], Thompson
et al. [141] showed a decrease in the proportion of type IIx
muscle fibers in the vastus lateralis in participants com-
pleting SIT with NO3
- but not in the other conditions.
Based on the findings of these studies, it is possible that
NO3
- may elicit similar muscle fiber-type changes when
consumed parallel to training in normoxia and hypoxia but
may be more effective at enhancing performance adapta-
tions to normoxic than hypoxic training. However, this
requires direct investigation given the multifarious
methodological differences between studies. In particular,
Puype et al. [138] and De Smet et al. [139] in hypoxia
recruited moderately trained participants ( _VO2max: *51–
60 mlkg-1min-1), whereas Muggeridge et al. [140] and
Thompson et al. [141] in normoxia recruited individuals
with lower aerobic fitness ( _VO2max: *42–50 mlkg-1-
min-1), who may exhibit a greater response to training
with NO3
-.
The approach adopted in the above studies is similar to
most training-intervention studies, whereby a standardized
exercise session is utilized throughout the intervention,
either with or without an overload component [142–145].
This strategy is seldom adopted by ‘real-world’ athletes,
who instead perform a wide variety of training sessions
[146–148]. Interestingly, anecdotal reports suggest that
some elite endurance athletes at high-altitude training
camps selectively use NO3
- supplements (e.g., beetroot
juice) in an attempt to maximize performance in some, but
not all, training sessions. This approach, first highlighted
by Professor Andrew Jones of Exeter University, UK
[31, 32], may allow athletes to benefit from conducting key
training sessions at higher exercise intensities. Conversely,
low-intensity high-mileage sessions are performed unsup-
plemented, thus maximizing the hypoxic stimulus for
adaptation [31, 32]. Periodizing NO3
- supplementation in
hypoxia has yet to be evaluated scientifically but may offer
valuable psychological advantages to athletes regardless of
the potential physiological merits.
6 Summary and Conclusions
NO3
- supplementation is emerging as a promising nutri-
tional aid, with potentially beneficial applications for the
wide variety of individuals ascending to altitude each year.
In this review, NO3
- supplementation has been demon-
strated to reduce pulmonary _VO2 and, in some cases, ele-
vate SaO2 in normobaric hypoxia—effects that may be
attributable to improvements in the efficiency of muscle
contraction and/or mitochondrial respiration, and are of
functional relevance for individuals exercising in a low-O2
environment. Current evidence also suggests that NO3
-
supplementation can improve muscle energetics during
exercise in normobaric hypoxia via effects on tissue O2
delivery and consumption and might alter cardiovascular
responses to normobaric and hypobaric hypoxia. In
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contrast, whilst NO3
- supplementation might influence
some of the physiological responses to hypoxic training,
current evidence suggests that this does not translate into
improved exercise performance in normoxia. Given that
the majority of published investigations have explored the
effects of NO3
- supplementation in simulated altitude,
which is often regarded as an incomplete surrogate of
‘‘true’’ altitude, future studies at terrestrial altitude are
necessary. Researchers are encouraged to further probe the
myriad potentially beneficial effects of NO3
- supplemen-
tation as a potential aid to ‘‘beet-ing’’ the mountain.
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